Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Citrobacter freundii is a worldwide emerging nosocomial pathogen with escalating incidence of multidrug resistance. Citrobacter freundii exists in natural environment, especially in health care settings and is difficult to eradicate. Phage therapy is considered as an alternative way of controlling bacterial infections and contaminations. In this study, we have described isolation and characterization of a virulent bacteriophage LK1 capable of specifically infecting Citrobacter freundii. A virulent bacteriophage LK1, specific for Citrobacter freundii was isolated from sewage water sample. TEM showed that phage Lk1 has an icosahedral head 70 nm in diameter and short tail of 17 nm, and can be classified as a member of the Podoviridae family. Restriction analysis indicated that phage LK1 was a dsDNA virus with an approximate genome size of 20-23 kb. Proteomic pattern generated by SDS PAGE using purified LK1 phage particles, revealed three major and six minor protein bands with molecular weight ranging from 25 to 80 kDa. Adsorption rate of LK1 relative to the host bacterium was also determined which showed significant improvement in adsorption with the addition of CaCl2 . In a single step growth experiment, LK1 exhibited a latent period of 24 min and burst size of 801 particle/cell. Moreover, pH and thermal stability of phage LK1 demonstrated a pH range of 5.0-6.0 and phage viability decreased to 0% at 65 °C. When LK1 was used to infect six other clinically isolated pathogenic strains, it showed relatively narrow host range. LK1 was capable of eliciting efficient lysis of Citrobacter freundii, revealing its potential as a non-toxic sanitizer for controlling Citrobacter freundii infection and contamination in both hospital and other public environments.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jobm.201200710DOI Listing

Publication Analysis

Top Keywords

citrobacter freundii
28
virulent bacteriophage
12
bacteriophage lk1
12
phage lk1
12
lk1
11
characterization virulent
8
lk1 specific
8
specific citrobacter
8
freundii isolated
8
isolated sewage
8

Similar Publications

Citrobacter freundii, a common zoonotic pathogen affecting humans, livestock and fish, is recognized for its substantial impact on largemouth bass (Micropterus salmoides) mortality. However, the mechanisms of C. freundii infection in largemouth bass remain poorly understood.

View Article and Find Full Text PDF

Background: Escherichia coli (EC), Escherichia fergusonii (EF), and Citrobacter freundii (CF) are clinically significant Gram-negative bacteria that are difficult to differentiate because of their shared 16S rRNA gene sequences.

Methods: This study presents a novel approach utilizing adenylate kinase (adk) gene polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis for the precise discrimination of EC, EF, and CF. Analysis of adk sequences revealed unique restriction sites for BtsIMutI, BtgI, and AgeI restriction enzymes at nucleotide positions 93 and 96.

View Article and Find Full Text PDF

Fuchka, a popular street food across Bangladesh and the Indian subcontinent, poses potential public health risk due to substandard hygienic practice during preparation and handling. This study evaluated the microbiological quality of and its associated components and identified food-borne bacteria with their antibiogram profiles within a One Health framework. 60 samples including fuchka, salad, hand wash, and dish wash water were collected from street vendors, shop, and restaurants within the Mymensingh City Corporation area (4 samples × 15 sites).

View Article and Find Full Text PDF

Unique Regulation of Sed-1 β-Lactamase in : Insights on Resistance to Third-Generation Cephalosporin.

Antibiotics (Basel)

August 2025

Department of Microbiology and Infectious Diseases, Nara Medical University, 840 Shijo-cho, Kashihara 6348521, Nara, Japan.

The genus harbors class C (AmpC) and class A β-lactamases. produces an inducible AmpC β-lactamase controlled by the LysR-type transcriptional regulator AmpR and cytosolic amidase AmpD. produces the class A β-lactamase Sed-1, whose expression is believed to be regulated by the transcriptional regulator SedR and AmpD.

View Article and Find Full Text PDF

The rise of microorganisms that are resistant to drugs is one of the significant challenges facing the health sector. The need to identify effective alternatives facing bacterial diseases is significantly highlighted. Nanomaterials have the potential to be a game-changing weapon in the battle against infectious diseases.

View Article and Find Full Text PDF